3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
182
Ovarian Neoplasms
92
Carcinoma, Ovarian Epithelial
46
Fallopian Tube Neoplasms
35
Endometrial Neoplasms
29
Peritoneal Neoplasms
23
Stomach Neoplasms
18
Colorectal Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Neoplasms
11
Vulvar Neoplasms
9
Recurrence
9
Lung Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Pancreatic Neoplasms
7
Locally Advanced Cervical Cancer
7
Brenner Tumor
7
Uterine Neoplasms
6
Testicular Neoplasms
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasm Metastasis
6
Carcinoma
6
Urinary Bladder Neoplasms
5
Sarcoma
5
Colonic Neoplasms
5
Breast Neoplasms
5
Vaginal Neoplasms
4
Triple Negative Breast Neoplasms
4
Teratoma
4
Small Cell Lung Carcinoma
4
Interventions
Doxorubicin
6
Ifosfamide
4
Filgrastim
3
belinostat
2
Radiotherapy
2
Imatinib Mesylate
2
sodium thiosulfate
1
saracatinib
1
perifosine
1
brostallicin
1
X-Rays
1
Vincristine
1
Trabectedin
1
Therapeutics
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Injections
1
Immunotherapy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fulvestrant
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Cisplatin
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled